Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forte Biotechnology is a biotechnology company specializing in on-site diagnostic solutions for the aquaculture and agriculture sectors. The company's core technology, the RAPID (Robust and Portable Integrated Detection) platform, enables farmers to perform high-accuracy molecular testing for devastating pathogens, such as White Spot Syndrome Virus, directly at the farm level. This eliminates the need for centralized laboratory testing and allows for rapid intervention to prevent widespread crop loss. Forte Biotechnology's mission is to enhance global food security by providing accessible and cost-effective disease monitoring tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forte Biotechnology.